CL2025001805A1 - Agonistas del receptor de amilina - Google Patents

Agonistas del receptor de amilina

Info

Publication number
CL2025001805A1
CL2025001805A1 CL2025001805A CL2025001805A CL2025001805A1 CL 2025001805 A1 CL2025001805 A1 CL 2025001805A1 CL 2025001805 A CL2025001805 A CL 2025001805A CL 2025001805 A CL2025001805 A CL 2025001805A CL 2025001805 A1 CL2025001805 A1 CL 2025001805A1
Authority
CL
Chile
Prior art keywords
amylin receptor
receptor agonists
compound
pharmaceutical composition
relates
Prior art date
Application number
CL2025001805A
Other languages
English (en)
Spanish (es)
Inventor
Mia Jørgensen Cecilie
Kruse Thomas
F Lau Jesper
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US18/512,512 external-priority patent/US12116388B2/en
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of CL2025001805A1 publication Critical patent/CL2025001805A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CL2025001805A 2022-12-22 2025-06-17 Agonistas del receptor de amilina CL2025001805A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22215958 2022-12-22
US18/512,512 US12116388B2 (en) 2022-12-22 2023-11-17 Amylin receptor agonists

Publications (1)

Publication Number Publication Date
CL2025001805A1 true CL2025001805A1 (es) 2025-09-26

Family

ID=89542238

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2025001805A CL2025001805A1 (es) 2022-12-22 2025-06-17 Agonistas del receptor de amilina

Country Status (12)

Country Link
EP (1) EP4638480A1 (https=)
JP (1) JP2025542410A (https=)
KR (1) KR20250127104A (https=)
CN (1) CN120435491A (https=)
AU (1) AU2023411346A1 (https=)
CL (1) CL2025001805A1 (https=)
CO (1) CO2025008319A2 (https=)
IL (1) IL321586A (https=)
JO (1) JOP20250144A1 (https=)
MX (1) MX2025007124A (https=)
TW (1) TW202428309A (https=)
WO (1) WO2024133739A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008006A1 (en) 1992-09-30 1994-04-14 Zymogenetics, Inc. Human calcitonin receptor
ES2401965T3 (es) 2009-02-19 2013-04-25 Novo Nordisk A/S Modificación de Factor VIII
JP6121992B2 (ja) 2011-06-10 2017-04-26 ノヴォ ノルディスク アー／エス ポリペプチド
AR097701A1 (es) * 2013-09-19 2016-04-13 Zealand Pharma As Análogos de amilina
JP6898518B2 (ja) 2018-02-02 2021-07-07 ノヴォ ノルディスク アー／エス Ｇｌｐ−１アゴニスト、ｎ−（８−（２−ヒドロキシベンゾイル）アミノ）カプリル酸の塩及び滑沢剤を含む固形組成物
TWI829687B (zh) 2018-05-07 2024-01-21 丹麥商諾佛 儂迪克股份有限公司 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物

Also Published As

Publication number Publication date
TW202428309A (zh) 2024-07-16
KR20250127104A (ko) 2025-08-26
CN120435491A (zh) 2025-08-05
EP4638480A1 (en) 2025-10-29
CO2025008319A2 (es) 2025-07-17
MX2025007124A (es) 2025-07-01
JP2025542410A (ja) 2025-12-25
IL321586A (en) 2025-08-01
AU2023411346A1 (en) 2025-07-24
WO2024133739A1 (en) 2024-06-27
JOP20250144A1 (ar) 2025-06-16

Similar Documents

Publication Publication Date Title
CO2023008866A2 (es) Coagonistas de los receptores de glp-1 y amilina
AR127945A1 (es) Formulaciones farmacéuticas que comprenden un agonista del receptor de amilina, un agonista del receptor de glp-1 y una ciclodextrina
MX2022009523A (es) Formulaciones farmaceuticas.
CY1124104T1 (el) Δισκιο διασπειρομενο στο στομα περιεχον οιστετρολη
MX2019002265A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
BR112015019264A8 (pt) cápsulas para o tratamento de helicobacter pylori e seu uso".
CL2017003208A1 (es) Unidad de dosificación orodispersable que contiene un componente estetrol
ZA202107825B (en) Pharmaceutical parenteral composition of dual glp1/2 agonist
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
JOP20250310A1 (ar) صيغ صيدلية لمساعد مستقبل أميلين ومساعد مستقبل 1-glp مشتملة على سيكلودكسترين
MX2020007760A (es) Composiciones y metodos para mejorar la biodisponibilidad de 5-hidroxitriptofano.
CO2024002256A2 (es) Formas de dosificación gastrorretentivas de 5-hidroxitriptófano
AR102778A1 (es) Composición farmacéutica, su preparación y sus usos
CL2025001805A1 (es) Agonistas del receptor de amilina
AR065139A1 (es) Medicamento para el tratamiento de la endometriosis
AR131469A1 (es) Agonistas del receptor de amilina
CL2025003984A1 (es) Semaglutida en terapia médica.
CR20190203A (es) Composición farmacéutica con antagonista del receptor de mineralocorticoides y su uso
CO2025006863A2 (es) Métodos para el tratamiento de la obesidad
PE20130782A1 (es) Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo
MX2025000669A (es) Formulaciones inhalables de agonistas de receptores de serotonina
AR129775A1 (es) Composición farmacéutica que contiene agonista del receptor de adenosina a3 para el tratamiento de la psoriasis
AR134511A1 (es) Triagonistas de los receptores de glp-1, gip y amilina
CR20220046A (es) Composiciones farmacéuticas para péptidos co-agonistas de glucagón y glp-1
TW202615455A (zh) 包含ｇｌｐ－１及澱粉素受體之共促效劑之醫藥調配物